GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:

ThinkEquity

Research Company [hlAlert]
Research is at the core of everything we do at ThinkEquity, and we're passionate about it. Employing a disciplined and rigorous process, we scrutinize the spectrum of forces at play in the growth sectors we cover. Starting with a top
down analysis, we look closely at the megatrends and industry drivers that create opportunities for innovative companies. We then allocate our resources based on a long-range research roadmap that leads to deep domain expertise and a close working knowledge of the technologies, products, services and people that populate the growth sector landscape. In short, the sum result of the ThinkEquity research process is to identify and affiliate ourselves with the fastest growing private and public companies within our domain verticals.
URL : http://www.thinkequity.com/research/index.html
  
Rating:
Buy CTIC
3 Months Gains
up 35.11 %
CELL THERAPEUTICS (CTIC) rated Buy by ThinkEquity
Monday,  Oct 15, 2012  9:25 AM ET

Rating:
Buy CTIC
1 Day Gains
up 5.96 %
CELL THERAPEUTICS (CTIC) rated Buy by ThinkEquity
Monday,  Oct 15, 2012  9:25 AM ET

Rating:
Buy CTIC
1 Week Gains
up 3.63 %
CELL THERAPEUTICS (CTIC) rated Buy by ThinkEquity
Monday,  Oct 15, 2012  9:25 AM ET

Rating:
Buy CTIC
CELL THERAPEUTICS (CTIC) rated Buy by ThinkEquity
Monday,  Oct 15, 2012  9:25 AM ET

Rating:
Buy ACTA
1 Month Gains
up 88.18 %

Rating:
Buy ACTA
3 Months Gains
up 20.55 %

Rating:
Buy ACTA
3 Months Gains
up 12.50 %

Rating:
Buy ACTA
3 Months Gains
up 9.70 %

Rating:
Buy ULTI
3 Months Gains
up 7.11 %

Rating:
Buy ACTA
1 Week Gains
up 6.56 %

Rating:
Buy ULTI
3 Months Gains
up 6.40 %

Rating:
Buy ULTI
1 Day Gains
up 1.62 %

Rating:
Buy ULTI
1 Day Gains
up 1.26 %

Rating:
Buy ACTA
1 Day Gains
up 0.69 %

Rating:
Buy ACTA
1 Day Gains
down 3.50 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy